5-Bromo-N-methylpyridine-3-sulfonamide

Catalog No. :
ACVQZL581
CAS No. :
173999-19-4
Molecular Formula :
C6H7BrN2O2S
Molecular Weight :
251.10

IUPAC Name:5-bromo-N-methylpyridine-3-sulfonamide

5-Bromo-N-methylpyridine-3-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g96%$231.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-N-methylpyridine-3-sulfonamide
IUPAC Name5-bromo-N-methylpyridine-3-sulfonamide
MDL No.MFCD11053860
Molecular FormulaC6H7BrN2O2S
Molecular Weight251.10
SMILESO=S(C1=CC(Br)=CN=C1)(NC)=O
InChI KeySNFZSCOGEYEYJG-UHFFFAOYSA-N
Synonym5-Bromo-N-methylpyridine-3-sulfonamide | 173999-19-4 | N-Methyl 5-bromopyridine-3-sulfonamide | SCHEMBL1771843 | DTXSID80674622 | SNFZSCOGEYEYJG-UHFFFAOYSA-N | YGA99919 | MFCD11053860 | AKOS011069327 | 5-bromo-N-methyl-3-pyridinesulfonamide | N-methyl-5-bromopyridine-3-sulfo
CAS No.173999-19-4
PubChem CID46738979

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACVQZL581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCJOK837 route compound structure diagram
    ACCJOK83765001-21-0 In Stock
  4. Then
  5. ACVQZL581 route product structure diagram
    ACVQZL581173999-19-4 In Stock
Inquiry

2. ACVQZL581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. ACCJOK837 route compound structure diagram
    ACCJOK83765001-21-0 In Stock
  6. Then
  7. ACVQZL581 route product structure diagram
    ACVQZL581173999-19-4 In Stock
Inquiry

Comments (0)